These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2684531)

  • 1. Rationale for using recombinant human erythropoietin to treat the anemia of prematurity.
    Phibbs RH; Shannon K; Mentzer WC
    Contrib Nephrol; 1989; 76():324-8; discussion 328-9. PubMed ID: 2684531
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin (r-HuEPO) increases total bilirubin production in premature infants.
    Baxter LM; Vreman HJ; Ball B; Stevenson DK
    Clin Pediatr (Phila); 1995 Apr; 34(4):213-6. PubMed ID: 7789015
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin in anemia of prematurity.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):80-4. PubMed ID: 23025776
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.
    Keyes WG; Donohue PK; Spivak JL; Jones MD; Oski FA
    Pediatrics; 1989 Sep; 84(3):412-7. PubMed ID: 2771544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating erythroid progenitors in the anemia of prematurity.
    Shannon KM; Naylor GS; Torkildson JC; Clemons GK; Schaffner V; Goldman SL; Lewis K; Bryant P; Phibbs R
    N Engl J Med; 1987 Sep; 317(12):728-33. PubMed ID: 3627181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant human erythropoietin--blood transfusion alternative].
    Morshakova EF
    Antibiot Khimioter; 2000; 45(12):27-9. PubMed ID: 11212490
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prevention of anemia in premature infants: the role of recombinant human erythropoietin in a level III neonatology department].
    Klosowski S; Kongolo G; Morisot C; Thelliez P; Djebara A; Deroubaix P
    Arch Pediatr; 1999 May; 6(5):592-4. PubMed ID: 10370824
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood extractions, transfusion policy and erythropoietin in the newborn].
    Figueras Aloy J; Carbonell Estrany X
    An Esp Pediatr; 1998 Jul; 49(1):46-8. PubMed ID: 9718766
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.
    Halpérin DS; Wacker P; Lacourt G; Félix M; Babel JF; Aapro M; Wyss M
    J Pediatr; 1990 May; 116(5):779-86. PubMed ID: 1691780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
    Dallman PR
    Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
    Ohls RK; Christensen RD
    J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants].
    Rabbani F
    Lik Sprava; 2002; (3-4):81-4. PubMed ID: 12145901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin therapy for anemia of prematurity.
    Gallagher PG; Ehrenkranz RA
    Clin Perinatol; 1993 Mar; 20(1):169-91. PubMed ID: 8458164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin and anemia in premature infants].
    Saizou C; Moriette G; Sauchez L
    Arch Pediatr; 2004 Dec; 11(12):1516-20. PubMed ID: 15596348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity".
    Christensen RD
    Pediatrics; 1989 May; 83(5):793-6. PubMed ID: 2717299
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin for anemia of cancer: higher hematocrits, fewer transfusions.
    Oncology (Williston Park); 1992 Sep; 6(9):19. PubMed ID: 1449973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.